Asia-Pacific Osteoarthritis Therapeutics Market: Estimation, Dynamics, Regional Share, Trends, Competitor Analysis (2017-2021) and Forecast (2022-2028)

$ PRICE - $ 3,000.00$ 8,900.00

Asia-Pacific Osteoarthritis Therapeutics Market: By Disease Type (Ankle Osteoarthritis, Hip Osteoarthritis, Knee Osteoarthritis, Shoulder Osteoarthritis, Others), by Drug Class (Viscosupplementation Agents, NSAIDs, Analgesics, Corticosteroids, Others), by Route of Administration (Oral, Topical, Parenteral), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) and Geography

$ PRICE - $ 3,000.00$ 8,900.00
Clear selection
Clear
$ PRICE - $ 3,000.00$ 8,900.00
FacebookTwitterLinkedinEmail

Report

Description

Asia-Pacific Osteoarthritis Therapeutics Market was valued at USD 7,500 million in 2021. It is expected to reach a value of USD 11,900 million by 2028, growing at a CAGR of 8.0% from 2022 to 2028. The market provides a detailed overview of the Asia-Pacific Osteoarthritis Therapeutics Market, which has been segmented by disease type, drug class, route of administration, and distribution channel. The market has been segmented by disease type into Ankle Osteoarthritis, Hip Osteoarthritis, Knee Osteoarthritis, Shoulder Osteoarthritis, and Others. The Knee Osteoarthritis segment is likely the most significant and fastest-growing segment in various disease types. The market has been segmented by drug class into Viscosupplementation Agents, NSAIDs, Analgesics, Corticosteroids, and Others. The Viscosupplementation Agents segment is expected to gain the maximum revenue share in the market over the forecast period 2022-2028. By route of administration, the Asia-Pacific osteoarthritis therapeutics market has been segmented into Oral, Topical, and Parenteral. The Parenteral segment accounted for the maximum revenue share. Based on the distribution channel, the Asia-Pacific Osteoarthritis Therapeutics is segmented into Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies. According to precision business insights, the Hospital Pharmacies segment is predicted to register the fastest growth rate during the forecast period.

Key Development:

In August 2020, Dr. Reddy’s Laboratories launched an over-the-counter Diclofenac Sodium topical gel used to treat arthritis pain in the US market.

Asia-Pacific Osteoarthritis Therapeutics Market

MARKET SUMMARY
-
8.0% CAGR
  • Study Period– 2022-2028
  • Base Year– 2021
  • CAGR– 8.0%
  • Fastest Growing Market– Asia-Pacific

Asia-Pacific Osteoarthritis Therapeutics Market

  • The asia-pacific osteoarthritis therapeutics market report gives comprehensive outlook across the region with special emphasis on key regions.
  • The asia-pacific osteoarthritis therapeutics market report gives historical, current, and future market sizes (US$ Mn) based on Disease Type, by Drug Class, by route of administration, by distribution channel and geography.
Key Players
  • Pfizer, Inc.
  • Novartis AG
  • Sanofi SA
  • Anika Therapeutics, Inc.
  • Flexion Therapeutics
Asia-Pacific Osteoarthritis Therapeutics Market Drivers

The growing incidence of damaged tissues or organs that can be treated with osteoarthritis therapeutics is driving the market. The product of cutting-edge medical innovations drives the market in the Asia-Pacific region.


Asia-Pacific Osteoarthritis Therapeutics Market

Latin America
Latin-America
North-America
North-America
Europe
Europe
Asia Pacific
Asia-Pacific
Middle East
Middle East

Key

Features of the Report

  • The asia-pacific osteoarthritis therapeutics market report provides granular level information about the market size, regional market share, historic market (2017-2021) and forecast (2022-2028)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments, and start-up details that are actively working in the market
  • The report provides a plethora of information about market entry strategies, regulatory framework, and reimbursement scenario
Asia-Pacific Osteoarthritis Therapeutics Market Segmentation


Location

GEOGRAPHY

Frequently Asked Questions

The Asia-Pacific Osteoarthritis Therapeutics Market is projected to expand at a CAGR of 8.0% during the forecast period.

The Asia-Pacific osteoarthritis therapeutics market is ​​​ Pfizer, Inc., Novartis AG, Sanofi SA, Anika Therapeutics, Inc., Flexion Therapeutics, Bayer AG, and Sorrento Therapeutics, OrthoTrophix, Inc., Horizon Therapeutics, and Abbott, Inc.

Asia-Pacific is the fastest-growing region for Asia-Pacific Osteoarthritis Therapeutics Market


Report

Table Of Content

1. Executive Summary
2. Asia-Pacific Osteoarthritis Therapeutics Market Introduction
2.1. Asia-Pacific Osteoarthritis Therapeutics Market – Taxonomy
2.2. Asia-Pacific Osteoarthritis Therapeutics Market –Definitions
2.2.1. Disease Type
2.2.2. Drug Class
2.2.3. Route of Administration
3. Asia-Pacific Osteoarthritis Therapeutics Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Asia-Pacific Osteoarthritis Therapeutics Market Dynamic Factors – Impact Analysis
3.6. Asia-Pacific Osteoarthritis Therapeutics Market – Competition Landscape
3.7. Epidemiology
4. Asia-Pacific Osteoarthritis Therapeutics Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028
4.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
4.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
4.3. Market Opportunity Analysis
5. Asia-Pacific Osteoarthritis Therapeutics Market, By Disease Type, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
5.1. Ankle Osteoarthritis
5.1.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
5.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.1.3. Market Opportunity Analysis
5.2. Hip Osteoarthritis
5.2.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
5.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.2.3. Market Opportunity Analysis
5.3. Knee Osteoarthritis
5.3.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
5.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.3.3. Market Opportunity Analysis
5.4. Shoulder Osteoarthritis
5.4.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
5.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.4.3. Market Opportunity Analysis
5.5. Others
5.5.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
5.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.5.3. Market Opportunity Analysis
6. Asia-Pacific Osteoarthritis Therapeutics Market Forecast, By Drug Class, 2017 – 2021 and Forecast, 2022 – 2028
6.1. Viscosupplementation Agents
6.1.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.1.3. Market Opportunity Analysis
6.2. NSAIDs
6.2.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.2.3. Market Opportunity Analysis
6.3. Analgesics
6.3.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
6.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.3.3. Market Opportunity Analysis
6.4. Corticosteroids
6.4.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
6.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.4.3. Market Opportunity Analysis
6.5. Others
6.5.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
6.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.5.3. Market Opportunity Analysis
7. Asia-Pacific Osteoarthritis Therapeutics Market Forecast, By Route of Administration, 2017 – 2021 and Forecast, 2022 – 2028
7.1. Oral
7.1.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.1.3. Market Opportunity Analysis
7.2. Topical
7.2.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.2.3. Market Opportunity Analysis
7.3. Parenteral
7.3.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.3.3. Market Opportunity Analysis
8. Asia-Pacific Osteoarthritis Therapeutics Market Forecast, By Distribution Channel, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
8.1. Hospital Pharmacies
8.1.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
8.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.1.3. Market Opportunity Analysis
8.2. Retail Pharmacies
8.2.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
8.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.2.3. Market Opportunity Analysis
8.3. Online Pharmacies
8.3.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
8.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.3.3. Market Opportunity Analysis
9. Asia-Pacific Osteoarthritis Therapeutics Market Forecast, By Region, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
9.1. Japan
9.1.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
9.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.1.3. Market Opportunity Analysis
9.2. China
9.2.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
9.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.2.3. Market Opportunity Analysis
9.3. India
9.3.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
9.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.3.3. Market Opportunity Analysis
9.4. South Korea
9.4.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
9.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.4.3. Market Opportunity Analysis
9.5. Australia & New Zealand
9.5.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
9.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.5.3. Market Opportunity Analysis
9.6. ASEAN
9.6.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
9.6.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.6.3. Market Opportunity Analysis
9.7. Rest of Asia-Pacific
9.7.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
9.7.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.7.3. Market Opportunity Analysis
9.8. Asia-Pacific Osteoarthritis Therapeutics Market – Opportunity Analysis Index, By Disease Type, Drug Class, Route of Administration, Distribution Channel, and Country, 2022 – 2028
10. Japan Osteoarthritis Therapeutics Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
10.1. Disease Type Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
10.1.1. Ankle Osteoarthritis
10.1.2. Hip osteoarthritis
10.1.3. Knee Osteoarthritis
10.1.4. Shoulder Osteoarthritis
10.1.5. Others
10.2. Drug Class Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
10.2.1. Viscosupplementation Agents
10.2.2. NSAIDs
10.2.3. Analgesics
10.2.4. Corticosteroids
10.2.5. Others
10.3. Route of Administration Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
10.3.1. Oral
10.3.2. Topical
10.3.3. Parenteral
10.4. Distribution Channel Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
10.4.1. Hospital Pharmacies
10.4.2. Retail Pharmacies
10.4.3. Online Pharmacies
10.5. Japan Osteoarthritis Therapeutics Market Dynamics – Trends
11. China Osteoarthritis Therapeutics Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
11.1. Disease Type Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
11.1.1. Ankle Osteoarthritis
11.1.2. Hip osteoarthritis
11.1.3. Knee Osteoarthritis
11.1.4. Shoulder Osteoarthritis
11.1.5. Others
11.2. Drug Class Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
11.2.1. Viscosupplementation Agents
11.2.2. NSAIDs
11.2.3. Analgesics
11.2.4. Corticosteroids
11.2.5. Others
11.3. Route of Administration Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
11.3.1. Oral
11.3.2. Topical
11.3.3. Parenteral
11.4. Distribution Channel Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
11.4.1. Hospital Pharmacies
11.4.2. Retail Pharmacies
11.4.3. Online Pharmacies
11.5. China Osteoarthritis Therapeutics Market Dynamics – Trends
12. India Osteoarthritis Therapeutics Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
12.1. Disease Type Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
12.1.1. Ankle Osteoarthritis
12.1.2. Hip osteoarthritis
12.1.3. Knee Osteoarthritis
12.1.4. Shoulder Osteoarthritis
12.1.5. Others
12.2. Drug Class Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
12.2.1. Viscosupplementation Agents
12.2.2. NSAIDs
12.2.3. Analgesics
12.2.4. Corticosteroids
12.2.5. Others
12.3. Route of Administration Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
12.3.1. Oral
12.3.2. Topical
12.3.3. Parenteral
12.4. Distribution Channel Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
12.4.1. Hospital Pharmacies
12.4.2. Retail Pharmacies
12.4.3. Online Pharmacies
12.5. India Osteoarthritis Therapeutics Market Dynamics – Trends
13. South Korea Osteoarthritis Therapeutics Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
13.1. Disease Type Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
13.1.1. Ankle Osteoarthritis
13.1.2. Hip osteoarthritis
13.1.3. Knee Osteoarthritis
13.1.4. Shoulder Osteoarthritis
13.1.5. Others
13.2. Drug Class Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
13.2.1. Viscosupplementation Agents
13.2.2. NSAIDs
13.2.3. Analgesics
13.2.4. Corticosteroids
13.2.5. Others
13.3. Route of Administration Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
13.3.1. Oral
13.3.2. Topical
13.3.3. Parenteral
13.4. Distribution Channel Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
13.4.1. Hospital Pharmacies
13.4.2. Retail Pharmacies
13.4.3. Online Pharmacies
13.5. South Korea Osteoarthritis Therapeutics Market Dynamics – Trends
14. Australia & New Zealand Osteoarthritis Therapeutics Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
14.1. Disease Type Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
14.1.1. Ankle Osteoarthritis
14.1.2. Hip osteoarthritis
14.1.3. Knee Osteoarthritis
14.1.4. Shoulder Osteoarthritis
14.1.5. Others
14.2. Drug Class Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
14.2.1. Viscosupplementation Agents
14.2.2. NSAIDs
14.2.3. Analgesics
14.2.4. Corticosteroids
14.2.5. Others
14.3. Route of Administration Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
14.3.1. Oral
14.3.2. Topical
14.3.3. Parenteral
14.4. Distribution Channel Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
14.4.1. Hospital Pharmacies
14.4.2. Retail Pharmacies
14.4.3. Online Pharmacies
14.5. Australia & New Zealand Osteoarthritis Therapeutics Market Dynamics – Trends
15. Australia & New Zealand Osteoarthritis Therapeutics Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
15.1. Disease Type Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
15.1.1. Ankle Osteoarthritis
15.1.2. Hip osteoarthritis
15.1.3. Knee Osteoarthritis
15.1.4. Shoulder Osteoarthritis
15.1.5. Others
15.2. Drug Class Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
15.2.1. Viscosupplementation Agents
15.2.2. NSAIDs
15.2.3. Analgesics
15.2.4. Corticosteroids
15.2.5. Others
15.3. Route of Administration Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
15.3.1. Oral
15.3.2. Topical
15.3.3. Parenteral
15.4. Distribution Channel Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
15.4.1. Hospital Pharmacies
15.4.2. Retail Pharmacies
15.4.3. Online Pharmacies
15.5. Australia & New Zealand Osteoarthritis Therapeutics Market Dynamics – Trends
16. Rest of Asia-Pacific Osteoarthritis Therapeutics Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
16.1. Disease Type Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
16.1.1. Ankle Osteoarthritis
16.1.2. Hip osteoarthritis
16.1.3. Knee Osteoarthritis
16.1.4. Shoulder Osteoarthritis
16.1.5. Others
16.2. Drug Class Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
16.2.1. Viscosupplementation Agents
16.2.2. NSAIDs
16.2.3. Analgesics
16.2.4. Corticosteroids
16.2.5. Others
16.3. Route of Administration Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
16.3.1. Oral
16.3.2. Topical
16.3.3. Parenteral
16.4. Distribution Channel Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
16.4.1. Hospital Pharmacies
16.4.2. Retail Pharmacies
16.4.3. Online Pharmacies
16.5. Australia & New Zealand Osteoarthritis Therapeutics Market Dynamics – Trends
17. Competition Landscape 
17.1. Strategic Dashboard of Top Market Players
17.2. Company Profiles (Introduction, Financial Analysis, Disease Type & Service Offerings, Key Developments, Strategies, and SWOT Analysis)
17.2.1. Pfizer, Inc.
17.2.2. Novartis AG
17.2.3. Sanofi SA
17.2.4. Anika Therapeutics, Inc.
17.2.5. Flexion Therapeutics
17.2.6. Bayer AG
17.2.7. Sorrento Therapeutics
17.2.8. OrthoTrophix, Inc.
17.2.9. Horizon Therapeutics
17.2.10. Abbott, Inc.
18. Research Methodology
19. Key Assumptions and Acronyms

Report

Company Profile

  • Pfizer, Inc.
  • Novartis AG
  • Sanofi SA
  • Anika Therapeutics, Inc.
  • Flexion Therapeutics
  • Bayer AG
  • Sorrento Therapeutics
  • OrthoTrophix, Inc.
  • Horizon Therapeutics
  • Abbott, Inc

Description

Asia-Pacific Osteoarthritis Therapeutics Market was valued at USD 7,500 million in 2021. It is expected to reach a value of USD 11,900 million by 2028, growing at a CAGR of 8.0% from 2022 to 2028. The market provides a detailed overview of the Asia-Pacific Osteoarthritis Therapeutics Market, which has been segmented by disease type, drug class, route of administration, and distribution channel. The market has been segmented by disease type into Ankle Osteoarthritis, Hip Osteoarthritis, Knee Osteoarthritis, Shoulder Osteoarthritis, and Others. The Knee Osteoarthritis segment is likely the most significant and fastest-growing segment in various disease types. The market has been segmented by drug class into Viscosupplementation Agents, NSAIDs, Analgesics, Corticosteroids, and Others. The Viscosupplementation Agents segment is expected to gain the maximum revenue share in the market over the forecast period 2022-2028. By route of administration, the Asia-Pacific osteoarthritis therapeutics market has been segmented into Oral, Topical, and Parenteral. The Parenteral segment accounted for the maximum revenue share. Based on the distribution channel, the Asia-Pacific Osteoarthritis Therapeutics is segmented into Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies. According to precision business insights, the Hospital Pharmacies segment is predicted to register the fastest growth rate during the forecast period.

Key Development:

In August 2020, Dr. Reddy’s Laboratories launched an over-the-counter Diclofenac Sodium topical gel used to treat arthritis pain in the US market.

Reviews

There are no reviews yet.

Be the first to review “Asia-Pacific Osteoarthritis Therapeutics Market: Estimation, Dynamics, Regional Share, Trends, Competitor Analysis (2017-2021) and Forecast (2022-2028)”

Your email address will not be published. Required fields are marked *

ASIA PACIFIC OFFICE

Precision Business Insights, 5th Floor, Mohan’s Elite, Opp : Bharat Petroleum Pump, Khanamet Road, Hitech City, Hyderabad – 500084

EUROPE OFFICE

Precision Business Insights, Kemp House, 152 – 160 City Road, London EC1V 2NX